Qualcomm (QCOM) shares are declining in premarket trading as its licensing revenue comes in below expectations; Eli Lilly (LLY) beats adjusted profit estimates but misses them on weight-loss drug ...

Earnings are in focus following the latest quarterly reports from Qualcomm (QCOM), Arm (ARM), Ford (F), Eli Lilly (LLY), Roblox (RBLX), Hershey (HSY), and many more. Eyes are also on Amazon (AMZN ...

The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

Eli Lilly is set to report fourth-quarter earnings early Thursday, with analysts expecting rising sales and profit in the first full quarter with the company's weight-loss drugs no longer in shortage.

Eli Lilly’s momentum stems from blockbuster GLP-1 therapies (Mounjaro, Zepbound), fuelling revenue growth, long-term margin expansion, and an ethos driving America’s health focus across ...